Variant report
Variant | nsv550018 |
---|---|
Chromosome Location | chr10:16244094-16279015 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr10:16274419-16274579 | HepG2 | liver: | n/a | chr10:16274475-16274486 |
2 | CEBPB | chr10:16274441-16274545 | A549 | lung: | n/a | chr10:16274475-16274486 |
3 | CEBPB | chr10:16254419-16254431 | A549 | lung: | n/a | n/a |
4 | CTCF | chr10:16273720-16273870 | GM12871 | blood: | n/a | n/a |
5 | CTCF | chr10:16249540-16249690 | Caco-2 | colon: | n/a | n/a |
6 | CTCF | chr10:16245640-16245790 | HCFaa | heart: | n/a | n/a |
7 | CTCF | chr10:16248960-16249015 | GM10266 | blood: | n/a | n/a |
8 | CTCF | chr10:16258575-16258666 | GM10248 | blood: | n/a | n/a |
9 | E2F4 | chr10:16272498-16272524 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | E2F6 | chr10:16273706-16274023 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | EP300 | chr10:16276859-16277410 | SK-N-SH | brain: | n/a | n/a |
12 | GATA2 | chr10:16274421-16274853 | SH-SY5Y | brain: | n/a | n/a |
13 | GATA2 | chr10:16276926-16277413 | SH-SY5Y | brain: | n/a | n/a |
14 | GATA3 | chr10:16276997-16277208 | SH-SY5Y | brain: | n/a | n/a |
15 | GATA3 | chr10:16274360-16274911 | SH-SY5Y | brain: | n/a | n/a |
16 | JUN | chr10:16267349-16267640 | H1-hESC | embryonic stem cell: | n/a | chr10:16267440-16267453 |
17 | JUN | chr10:16278440-16278600 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | JUN | chr10:16267345-16267555 | HepG2 | liver: | n/a | chr10:16267440-16267453 |
19 | JUND | chr10:16255849-16256085 | HepG2 | liver: | n/a | chr10:16256002-16256013 |
20 | JUND | chr10:16267315-16267613 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | JUND | chr10:16267287-16267612 | HepG2 | liver: | n/a | n/a |
22 | KAP1 | chr10:16264881-16265476 | K562 | blood: | n/a | n/a |
23 | KAP1 | chr10:16264898-16265398 | HEK293 | kidney: | n/a | n/a |
24 | MAFK | chr10:16276177-16276191 | HepG2 | liver: | n/a | n/a |
25 | MXI1 | chr10:16262823-16262934 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | MYC | chr10:16263780-16263868 | GM12878 | blood: | n/a | n/a |
27 | POLR2A | chr10:16276447-16276559 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr10:16249933-16250085 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr10:16256418-16256454 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | POLR2A | chr10:16267642-16267798 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr10:16277229-16277338 | A549 | lung: | n/a | n/a |
32 | POLR2A | chr10:16262284-16262399 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | RCOR1 | chr10:16269820-16269950 | K562 | blood: | n/a | n/a |
34 | SETDB1 | chr10:16247998-16248341 | U2OS | brain: | n/a | n/a |
35 | SETDB1 | chr10:16264871-16265492 | U2OS | brain: | n/a | n/a |
36 | STAT3 | chr10:16275642-16275758 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | STAT3 | chr10:16244592-16244792 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | STAT3 | chr10:16277635-16277752 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | TRIM28 | chr10:16264848-16265176 | K562 | blood: | n/a | n/a |
40 | ZNF143 | chr10:16264986-16265219 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:16272567..16275355-chr10:16277483..16279973,2 | K562 | blood: | |
2 | chr10:16275723..16278095-chr10:16278831..16281522,2 | K562 | blood: | |
3 | chr10:16275723..16278095-chr10:16278831..16281522,2 | K562 | blood: | |
4 | chr10:16272567..16275355-chr10:16277483..16279973,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-1075P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549217270 | chr10:16247209-16247210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556545117 | chr10:16247231-16247232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113454087 | chr10:16247253-16247254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs184269399 | chr10:16247300-16247301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs12778353 | chr10:16247310-16247311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553230584 | chr10:16247314-16247315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571753415 | chr10:16247316-16247317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539099540 | chr10:16247353-16247354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574879457 | chr10:16247377-16247378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1578265 | chr10:16247399-16247400 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs61065714 | chr10:16249989-16249990 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs537945293 | chr10:16250037-16250038 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs552029482 | chr10:16250062-16250063 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs570435075 | chr10:16250076-16250077 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs370791833 | chr10:16257408-16257409 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs112639595 | chr10:16257417-16257418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572950453 | chr10:16257427-16257428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147902079 | chr10:16257451-16257452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564947534 | chr10:16257460-16257461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141586310 | chr10:16257466-16257467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs71493247 | chr10:16257479-16257480 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs562499149 | chr10:16257532-16257533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530073251 | chr10:16257545-16257546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1340139 | chr10:16257548-16257549 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs147032008 | chr10:16257591-16257592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1340138 | chr10:16257615-16257616 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs570982419 | chr10:16257622-16257623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148067797 | chr10:16257644-16257645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs117347518 | chr10:16257648-16257649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575303102 | chr10:16257686-16257687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs56380644 | chr10:16257694-16257695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536301090 | chr10:16257715-16257716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374251746 | chr10:16257722-16257723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554884383 | chr10:16257739-16257740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1340137 | chr10:16257742-16257743 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs540177783 | chr10:16257750-16257751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187158656 | chr10:16257763-16257764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565044281 | chr10:16257765-16257766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190989182 | chr10:16257769-16257770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576973747 | chr10:16257794-16257795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536509107 | chr10:16257815-16257816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10904688 | chr10:16257823-16257824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs374399442 | chr10:16257827-16257828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530012370 | chr10:16257854-16257855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112530964 | chr10:16257872-16257873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs548210754 | chr10:16257884-16257885 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10904689 | chr10:16257952-16257953 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs1934638 | chr10:16257990-16257991 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs184938068 | chr10:16258069-16258070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150144832 | chr10:16258070-16258071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
DiGeorge-Velo cardiofacial | 22470819 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Lung cancer | 16773561 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 22048815 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Thymic lymphomas tumor | 22700994 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:16247200-16247400 | Weak transcription | Aorta | Aorta |
2 | chr10:16257400-16257800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr10:16257800-16262200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr10:16264200-16264600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr10:16264400-16264600 | ZNF genes & repeats | iPS-15b Cell Line | embryonic stem cell |
6 | chr10:16264600-16266600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr10:16267000-16267200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr10:16270000-16271600 | Weak transcription | Fetal Brain Male | brain |
9 | chr10:16271000-16271400 | Enhancers | H9 Cell Line | embryonic stem cell |
10 | chr10:16271000-16271400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr10:16271400-16273600 | Weak transcription | H9 Cell Line | embryonic stem cell |
12 | chr10:16271600-16271800 | Enhancers | Fetal Brain Male | brain |
13 | chr10:16271800-16272200 | Weak transcription | Fetal Brain Male | brain |
14 | chr10:16272200-16274800 | Enhancers | Fetal Brain Male | brain |
15 | chr10:16273200-16273400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr10:16273600-16273800 | Enhancers | Fetal Brain Female | brain |
17 | chr10:16273600-16274000 | Enhancers | H9 Cell Line | embryonic stem cell |
18 | chr10:16273800-16274200 | Flanking Active TSS | Fetal Brain Female | brain |
19 | chr10:16274200-16274400 | Enhancers | Fetal Brain Female | brain |
20 | chr10:16274800-16276800 | Weak transcription | Fetal Brain Male | brain |
21 | chr10:16276800-16277400 | Enhancers | Fetal Brain Male | brain |